Wallace Advisory Group, LLC / JNJ
Wallace Advisory Group, LLC’s Johnson & Johnson Position
Does Wallace Advisory Group, LLC own Johnson & Johnson (JNJ)? Yes — 6.2K shares worth $2M (+1.61% of its 13F portfolio) as of Q1 2026, down from 6.7K shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
6.2K
% of Portfolio
+1.61%
Quarters Held
14
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 6.2K | $2M | +1.61% |
| Q4 2025 | 6.7K | $1M | +1.46% |
| Q3 2025 | 8.5K | $1M | +1.05% |
| Q2 2025 | 9.5K | $2M | +1.14% |
| Q1 2025 | 6.4K | $929,907 | +0.64% |
| Q4 2024 | 6.5K | $1M | +0.73% |
| Q3 2024 | 6.7K | $984,095 | +0.72% |
| Q2 2024 | 6.8K | $993,596 | +0.72% |
| Q1 2024 | 7.4K | $1M | +0.87% |
| Q4 2023 | 7.6K | $1M | +0.93% |
| Q3 2023 | 7.9K | $1M | +0.93% |
| Q2 2023 | 7.9K | $1M | +0.93% |
| Q1 2023 | 7.9K | $1M | +0.93% |
| Q4 2022 | 7.9K | $1M | +1.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wallace Advisory Group, LLC’s full portfolio or all institutional holders of JNJ.